Brookline Capital Markets Reiterates Buy Rating on Intellia Therapeutics (NTLA), PT $106

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Brookline Capital Markets Reiterates Buy Rating on Intellia Therapeutics (NTLA), PT $106
(NASDAQ: NTLA) Delayed: 11.91 +0.08 (0.68%)
Previous Close $11.83    52 Week High $30.40 
Open $11.83    52 Week Low $11.86 
Day High $12.04    P/E N/A 
Day Low $11.41    EPS $0.00 
Volume 2,360,580